CELG : Analysis & Opinions

  1. Celgene 2016 Net $5.94 A Share On $11.2B In Sales

    January 11, 2017
    Celgene's 2016 earnings beat analyst estimates, and its 2017 forecast looks solid.
  2. Celgene Set to Buy Swiss Biotech Anokion for $45M

    January 10, 2017
    Celgene is getting ready to acquire Swiss biotech company Anokion for $45 million.
  3. Celgene Winding Up for 2017 Breakout (CELG, IBB)

    December 28, 2016
    Celgene is attracting steady buying interest after three successful tests at deep support and could enter a powerful 2017 ...
  4. Celgene, Acceleron Launch Blood Disorder Study (CELG)

    December 5, 2016
    Acceleron and Celgene are launching an ambitious trial to find a cure for a cancer-like blood disorder that will eliminate ...
  5. Celgene Buys Blood Cancer Specialist Acetylon (CELG)

    December 5, 2016
    Cash-rich Celgene expanded its cancer drug portfolio with the purchase of Boston-based Acetylon Pharmaceuticals.
  6. Celgene Invests More In Data Analytics Software (CELG)

    December 1, 2016
    Celgene hopes its second investment in GNS Healthcare's data analytics software will boost its drug development programs.
  7. Celgene Buys Brain Cancer Drug from Triphase (CELG)

    November 21, 2016
    Celgene bought an experimental brain cancer drug from Triphase Accelerator Corp.
  8. Big Pharma Battles over Psoriasis Market (NVS, CELG)

    November 17, 2016
    Major drug makers are battling for dominance of the lucrative psoriatic arthritis drug space.
  9. Biotechs to Buy After Trump Victory (CELG, BIIB)

    November 10, 2016
    The Trump win eases political pressure on biotech and pharmaceuticals stocks, allowing them to end their long corrections.(CELG,BIIB,SGEB)
  10. Celgene, IBM Team on Drug Monitoring (CELG, IBM)

    November 1, 2016
    Celgene agreed to use IBM's Watson Health platform to identify potential side effects in experimental drugs.
  11. Celgene 3Q Earnings Beat Street Estimates (CELG)

    October 28, 2016
    Celgene 3Q earnings beat analyst estimates, thanks in part to blockbuster sales of the company's Revlimid cancer drug.
  12. Celgene Otezla Psoriasis Drug Wins NICE Nod (CELG)

    October 20, 2016
    Celgene's Otezla drug was recommended by the UK public health watchdog, NICE, to treat plaque psoriasis in England and Wales. ...
  13. Celgene Explores App to Collect Study Data (CELG)

    October 19, 2016
    Celgene and Sage Bionetworks are developing an iPhone app that will collect data for patients with chronic anemia for use ...
  14. Celgene Ozanimod Treats Ulcerative Colitis (CELG)

    October 18, 2016
    Celgene's Phase 2 study suggests its ozanimod drug is effective for treating ulcerative colitis disorder.
  15. Celgene Otezla Arthritis Drug Wins NICE Nod (CELG)

    October 12, 2016
    Celgene's Otezla drug for psoriatic arthritis earned NICE's recommendation as a pill alternative to injections despite its ...
  16. Celgene, Agios, Abbott Team For Test (CELG, AGIO)

    October 12, 2016
    Celgene and Agios will collaborate with Abbott Laboratories to develop a diagnostic test for leukemia using Abbott's proprietary ...
  17. Celgene’s Outcomes To Be Revealed at ESMO (CELG)

    October 7, 2016
    Celgene will present its new findings on the drugs Abraxane and Carbolatin at the European Society of Medical Oncology 2 ...
  18. Celgene Backs Neuro Startup (CELG)

    October 1, 2016
    Celgene’s continued spending on pharma deals crossed another milestone with the Abide Therapeutics deal.
  19. Two Big Biotechs Flash Bearish Signals

    September 30, 2016
    Biotech funds are trading near rally highs, but two popular blue chip components are struggling, a foretelling weakness that ...
  20. Celgene Outspends Big Pharmas in Deals (CELG)

    September 15, 2016
    Celgene's big-ticket spending on innovative deals and R&D is a high-risk, high-reward play for the company.
  21. Celgene’s Big Bet May Pay Off (CELG)

    September 15, 2016
    With positive top-line results, Celgene is on track to benefit from the ongoing study of its mongersen drug, developed to ...
  22. Top 5 Drug Stocks of 2016 (ABBV, JNJ)

    August 19, 2016
    Discover analyses of the top five drug stocks, and learn why investors should consider these stocks due to the stocks' attractive ...
  23. Celgene Set to Squeeze Short Sellers (CELG, IBB)

    July 28, 2016
    Celgene has broken out of a year-long descending triangle top and could enter a major short squeeze.
  24. Pfizer, Celgene Pursue Medivation (PFE, CELG)

    July 6, 2016
    Sanofi isn't the only one interested in Medivation. Pfizer and Celgene also signed confidentiality agreements.
  25. Big Biotech Set to Bounce Off Deep Lows (GILD, CELG)

    June 23, 2016
    Relative strength indicators in the biotech sector have hit their deepest oversold readings since 2008, predicting a strong ...
  26. 3 Expensive U.S. Large Cap ETFs Worth Your While (QQXT, FVD)

    May 16, 2016
    Discover the three ETFs that, despite their high expense ratios, are worthy of consideration due to low beta, high dividends ...
  27. Technology ETFs to Date 2016 Performance Review (XLK, VOX)

    April 27, 2016
    Exercise caution before buying shares of a biotech ETF based on a belief that the biotech sector will follow the broader ...
  28. The 3 Largest Health Care ETFs (XLV, IBB)

    April 25, 2016
    Find out which exchange-traded funds (ETFs) are the largest in terms of total assets under management (AUM) in the health ...
  29. Take Advantage of Biotech's Bear Market Bounce (IBB, CELG)

    April 6, 2016
    The biotech sector is waking up after a long slumber and could move higher in coming weeks.
  30. 3 Best Dividend-Paying U.S. Health Care Mutual Funds (VGHCX, ...

    April 2, 2016
    Find out which mutual funds are paying the highest dividend yields in the health care sector, which has underperformed all ...
  31. Arena Pharmaceuticals Extends Its Winning Streak (ARNA, CELG)

    March 28, 2016
    While Arena is riding a wave of optimism, the company must still execute on its own to get its shares out of penny stock ...
  32. 3 Round Number Setups at 100

    March 23, 2016
    These three stocks should enter trend advances, higher or lower after they resolve conflicted price action at 100.
  33. (IBB) iShares NASDAQ Biotech SPDR ETF: Top 5 Holdings

    March 16, 2016
    Take a close look at the strong fundamentals underlying the top five holdings of the iShares NASDAQBiotechnology ETF as it ...
  34. Is Celgene Stock Suitable for Your IRA or Roth IRA? (CELG)

    March 7, 2016
    Learn why Celgene stock is a good addition to your traditional or Roth IRA; which vehicle is better depends on your income ...
  35. Celgene's 3 Key Financial Ratios (CELG)

    March 3, 2016
    Learn about Celgene Corporation and its key financial ratios, such as the debt-to-equity (D/E) ratio, operating margin and ...
  36. The 5 Best Performing Stocks in the Last 20 Years (GMCR, CELG)

    February 27, 2016
    Find out which six stocks have performed the best over the past 20 years, which industries generated the most growth and ...
  37. The Biggest Risks of Investing in Celgene Stock (CELG)

    February 1, 2016
    Discover the biggest risks to investing in Celgene Corporation when reviewing fundamental analysis and other external factors ...
  38. The Top 5 Large Cap Biotechnology Stocks for 2016 (AMGN, BIIB)

    January 5, 2016
    Discover the top five biotechnology stocks for 2016. Learn each company's main revenue drivers and what factors cause their ...
  39. 3 Biotech Blue-Chip Companies to Keep an Eye On (AMGN, BIIB)

    December 23, 2015
    Discover three blue-chip biotech stocks you should keep your eye on in 2016. Despite recent struggles in the industry, these ...
  40. 3 Popular Healthcare Stocks in 2015 (CVS, AGN)

    December 23, 2015
    Discover the three most popular health care stocks of 2015, including an affordable stock that caught BlackRock Investment ...
  41. Key Financial Ratios to Analyze Biotech Companies (AMGN, GILD)

    August 20, 2015
    Explore the rapidly growing biotechnology industry, and learn some of the key financial ratios investors use to analyze companies ...
  42. Top 3 Biotech ETFs (XBI, IBB)

    August 14, 2015
    Learn about three popular ETFs in the biotechnology sector, how they differ, and which ones may be appropriate for long term ...
  43. Celgene Vs. Gilead: Vetting for the Best Biopharma

    August 14, 2015
    Read about the similarities between the drug companies Celgene and Gilead, and learn about promising potential drug candidates ...
  44. Avoid The Perfection Trap In Trading (CELG)

    August 12, 2015
    Avoid the perfection trap and make peace with the market’s high levels of systematic noise.
  45. Celgene To Buy Receptos For $7.2B; Analysts Mixed

    July 15, 2015
    Celgene Corporation and Receptos announced a definitive agreement in which CELG will acquire Receptos for $232 per share. ...
  46. Celgene's $1 Billion Deal to Fight Cancer

    July 3, 2015
    Wall Street analysts are weighing today on Celgene Corporation after the pharmaceutical giant announced a 10-year broad collaboration ...
  47. Celgene Does Something Surprising With Its Cash

    June 22, 2015
    Source: YCharts. Although shares of biotech blue-chip stock Celgene (NASDAQ: CELG) are relatively unchanged in 2015, shareholders ...
  48. Celgene and Agios Deliver Some Great "Bad" News

    June 17, 2015
    Though the JPMorgan Healthcare Conference and the American Society of Clinical Oncology annual meeting offer, arguably, ...
  49. Could This Tiny Company Threaten Celgene?

    June 12, 2015
    A deal between the small-cap biotech company Sorrento Therapeutics (NASDAQ: SRNE) and a biopharma venture capital company ...
  50. Celgene Takes a Step Back in CAR-T Immunotherapy

    June 8, 2015
    In 2013, Celgene Corp. inked a deal with bluebird bio in which the two companies would leverage their expertise to develop ...
  51. Celgene's 3 Most Important Collaborations

    May 26, 2015
    Biotech blue-chip stock Celgene (NASDAQ: CELG) is arguably the complete package for investors. Celgene has a deep pipeline ...
  52. 5 Things Celgene's Management Wants You to Know

    May 14, 2015
    It has been about two weeks since biotech blue-chip stock Celgene (NASDAQ: CELG) reported its first-quarter earnings results, ...
  53. Is This a Reason to Buy Celgene for the Long Haul?

    May 8, 2015
    Celgene Corporation (NASDAQ: CELG) recently reported intriguing results for luspatercept, a drug it's developing with Acceleron ...
  54. Why Celgene Is Betting on This Tiny Biotech

    April 30, 2015
    Celgene (NASDAQ: CELG) is handing over $100 million in cash and has agreed to pay up to an additional $385 million in milestone ...
  55. Celgene Earnings Preview: What You Need to Know

    April 24, 2015
    It's been quite the ride lately for shareholders in Celgene (NASDAQ: CELG), with the stock returning nearly 200% over the ...
  56. When Will Celgene's Key Patents Expire?

    April 1, 2015
    Drug developers like Celgene (NASDAQ: CELG) are constantly innovating new medicine to offset the risk of sliding sales tied ...
  57. Does Celgene Have Another Blockbuster on the Way?

    March 26, 2015
    Celgene (NASDAQ: CELG) is best known for its cancer medicines, but it could soon be much better known for therapies designed ...
  58. Why These Could Be 2015's 10 Best Biotech Stocks

    March 25, 2015
    A quick look at a 10 biotech companies that are poised to deliver for shareholders in 2015.
  59. 1 Biotech Stock I Wish Would Go On Sale (CELG)

    March 24, 2015
    Everyone likes a great deal, and there's no biotech stock I'd love to see go on sale more than Celgene (NASDAQ: CELG). Celgene's ...
  60. What Biotech Stock To Buy When The Market Tumbles?

    March 10, 2015
    Since 2013, Biotech's return has tripled the S&P 500, and that may mean that with the market slipping lately, biotech's leading ...
  61. How On-Balance Volume Reveals Market Players' Strategy

    February 11, 2015
    On-Balance Volume (OBV) reveals the intent of market players, often before price action generates a buy or sell signal.
  62. The Biggest Biotech Companies

    January 15, 2015
    These biotech firms want to revolutionize medicine. If successful, they may see high profits, but investing in these companies ...
  63. Who are Amgen Inc.'s (AMGN) main competitors?

    August 27, 2014
    Biotech giant Amgen (AMGN) list of competitors is lengthy and formidable. Learn the major companies Amgen competes with.
  64. 8 Stages Of New Drug Development

    July 29, 2013
    Understanding biotech data isn't easy. What is a clinical trial, what are the various phases, and why do the results of these ...